Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 35 filings·Updated 31 Jul 2026
Showing 10 of 35 filings.
31 Jul 20261 filing
Board Meeting

Sarda Proteins to hold board meeting on August 5, 2026 to consider fund-raising proposals

Meeting Details

  • Meeting scheduled for August 5, 2026; time and venue not disclosed.

Key Agenda Items

  • Proposal to raise funds via issuance of equity shares or convertible securities through permitted modes.
  • Any other items with permission of the chairperson.

Other Notes

  • Time and venue for the August 5, 2026 meeting not disclosed.
Filed 12:12View Source
30 Jul 20261 filing
AGM/EGMEGM

Sarda Proteins EGM discusses capital expansion, object clause changes, name change, and director appointments

Key resolutions

  • Resolution 1 (Special): Increase capital from ₹13 crore to ₹100 crore; MOA Clause V amended; voting pending.
  • Resolution 2 (Special): Alter Main Object Clause to align with future expansion plans; voting pending.
  • Resolution 3 (Ord): Regularise Gunvantray Zaladi as Non-Executive, Non-Independent Director; voting pending.
  • Resolution 4 (Ord): Regularise Shivam Zaladi as Non-Executive, Non-Independent Director; voting pending.
  • Resolution 5 (Ord): Appoint Shirish Dhirajlal Savaliya as Managing Director; voting pending.
  • Resolution 6 (Ord): Regularise and appoint Yagnik Satasiya as Non-Executive Chairperson; voting pending.
  • Resolution 7 (Special): Change company name to Fresita Proteins Limited; MOA/AOA amendments; voting pending.
  • Resolution 8 (Ord): Appoint Statutory Auditor to fill casual vacancy; voting pending.
  • Resolution 9 (Ord): Appoint Statutory Auditors for five-year term 2026-2031; voting pending.
  • Resolution 10 (Ord): Appoint Ms. Minal Surendra Jain as Independent Woman Director; voting pending.
Filed 11:59View Source
16 Jul 20262 filings
AGM/EGMEGM

Sarda Proteins adds three EGM agenda items: auditors appointments and Woman Independent Director

EGM addendum overview

  • EGM scheduled for 30 July 2026 via VC/OAVM; three new items added.
  • Items 8-9 are ordinary resolutions; Item 10 is a special resolution.
  • Addendum forms part of the EGM notice; original notice remains in effect.

Item 8 – Auditors: casual vacancy

  • Ordinary resolution to appoint M/s A H Mandaliya & Associates as statutory auditors for casual vacancy.
  • Auditors to conduct period ending 31 March 2026; remuneration fixed by management.
  • No promoter/director interests other than shareholding disclosed.

Item 9 – Auditors: five-year term

  • Ordinary resolution to appoint M/s A H Mandaliya & Associates for five-year term (FY 2026-27 to 2030-31).
  • No promoter/director interests other than shareholding disclosed.

Item 10 – Woman Independent Director

  • Special resolution to regularize Ms. Minal Surendra Jain as Woman Independent Director for five-year term from 15.07.2026.
  • None of the Directors or KMPs have interests in the resolution beyond shareholding.
Filed 17:40View Source
Company UpdateNewspaper Publication

Newspaper Publication for June 2026 Quarter Result

Filed 14:17View Source
15 Jul 20261 filing
Company UpdateChange in Management

Sarda Proteins appoints Independent Women Director and reconstitutes key board committees

Appointment of Independent Women Director

  • Minal Surendra Jain appointed Independent Women Director for 5-year term from 15 July 2026, subject to shareholders' approval.
  • Not liable to retire by rotation.
  • Profile: governance and regulatory compliance professional with SEBI and ROC experience.
  • Relationships: Not related to any director; not debarred by SEBI.

Committee Reconstitution

  • Reconstituted Audit Committee, Nomination and Remuneration Committee, and Stakeholders' Relationship Committee with immediate effect.
  • Impact on governance: committee composition updated accordingly.
Filed 18:10View Source
9 Jul 20261 filing
Board Meeting

Sarda Proteins to hold board meeting on July 15, 2026 to approve unaudited quarterly results; trading window closed

Board meeting details

  • Board meeting scheduled for July 15, 2026 (Wednesday) to consider unaudited results.
  • Unaudited financial results for quarter ended June 30, 2026 to be approved.
  • Trading window closed from July 1, 2026 until 48 hours after results declaration.
Filed 16:40View Source
8 Jul 20261 filing
Company UpdateCertificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

RTA certificate confirms dematerialisation/rematerialisation details for quarter ended 30 June 2026

Dematerialisation/rematerialisation update

  • Confirmation certificate from MUFG Intime India Pvt. Ltd., RTA, on dematerialisation/rematerialisation for quarter ended 30 June 2026.
Filed 17:52View Source
7 Jul 20261 filing
Company UpdateNewspaper Publication

NEWSPAPER PUBLICATION AS PER ATTACHED

Filed 16:32View Source
6 Jul 20262 filings
Company UpdateGeneral

Sarda Proteins fixes cut-off date and e-voting window for EGM on 30 July 2026

EGM voting timeline

  • Cut-off date fixed at 23 July 2026 for determining eligibility to vote.
  • Remote e-voting period runs 27 July 2026 9:00 AM to 29 July 2026 5:00 PM.
Filed 18:34View Source
AGM/EGMEGM

Sarda Proteins EGM proposes capital expansion, MOA changes, MD appointment, and name change

Item 1: Authorised Capital Increase

  • Ordinary; increase authorised capital to ₹100 crore by 10 crore shares of ₹10 and amend MOA V.

Item 2: Object Clause Expansion

  • Special; expand MOA main object to include agriculturists, agri-foods, processing, trading, and commodity exchange activities.

Item 3: Regularize Gunvantray Zaladi

  • Ordinary; regularize Gunvantray Jayantilal Zaladi as Non-Executive Director, appointed 08-12-2025, term until rotation.

Item 4: Regularize Shivam Zaladi

  • Ordinary; regularize Shivam Gunvantray Zaladi as Non-Executive Director, appointed 08-12-2025, term until rotation.

Item 5: MD Appointment

  • Special; appoint Shirish Dhirajlal Savaliya as Managing Director for five years from 04-07-2026, salary ₹2.1 lakh/month.

Item 6: Regularize Yagnik Satasiya

  • Ordinary; appoint Yagnik Satasiya as Non-Executive Chairperson for five years; not liable to retire by rotation.

Item 7: Name Change

  • Special; change company name to Sarda Enterprises Limited, subject to CRC/ROC approvals; MOA/Articles updated.
Filed 18:32View Source
Showing 10 of 35 filings